Skip to Main Content
LuminUltra
EnglishFrançais简体中文

LuminUltra CEO Pat Whalen joins UNB’s new Fulcrum advisory board on industry innovation

FREDERICTON, NB, Jan. 6, 2022 – LuminUltra CEO Pat Whalen has joined the advisory board of the University of New Brunswick’s (UNB) Fulcrum initiative.

The Fulcrum initiative is part of the university’s drive to support industry innovation, and this new advisory board brings together industry leaders to provide insight into UNB’s Research & Innovation Partnerships program.

“Strengthening the relationship between industry and academia is important for identifying and executing on opportunities that lead to economic growth,” said Pat Whalen, CEO of LuminUltra Technologies Ltd. “It’s also an honour to sit on a board with a range of leaders who have spent their careers demonstrating their commitment to innovation, collaboration, and growth.”

The five-member advisory board also includes Denis Caron, president and CEO of the Belledune Port Authority; Duncan Gallant, research and evaluation coordinator at the Joint Economic Development Initiative (JEDI); Alicia Roisman Ismach, head of Atlantic Fintech; and Beth Webster, vice-president, Populus Global Solutions.

UNB’s Fulcrum initiative, led by Vice-President (Research) David MaGee, explores how research partnership activities can best support economic and social growth in the region.

In addition to being LuminUltra’s President and CEO, Pat Whalen is active in the entrepreneurial community, serving as a board member and past chair of BioNB, coaching other business leaders, and holding memberships in a variety of professional organizations.

Media contact

John McNeil, Public Relations Manager
john.mcneil@luminultra.com
+1-506-292-6079

About LuminUltra

LuminUltra is a biotechnology leader with more than 25 years’ experience in the water space developing rapid, portable, and accurate microbial monitoring solutions. We are your first line of defense against microbial challenges with our range of diagnostic technologies and services including 2nd Generation ATP, automated ATP and qPCR.

Customers in more than 80 countries trust our technology, production reliability, and history of customer service excellence to deliver their essential services in a safe state. With operations across the globe, we work with a diverse range of customers to meet their specific needs.

LuminUltra fosters a culture of innovation and agility and is on an accelerated growth path, acquiring multiple companies in recent years after forming a partnership with XPV Water Partners.


LuminUltra Team

Founded in 1995, LuminUltra is a molecular biology diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring applications and was a key supplier of COVID-19 diagnostic testing reagents to the Government of Canada.

Dozens of Fortune 500 customers across more than 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe state.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now